Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection
Journal of Infection and Chemotherapy · 2023
DOI: 10.1016/j.jiac.2023.08.017 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Infection and Chemotherapy, 2023. Verfasst von Takumi Maruyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan. Hauptthemen laut MEDLINE: Vancomycin, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
INTRODUCTION: The latest therapeutic drug monitoring guidelines for vancomycin (VCM) recommend that area under the concentration-time curve is estimated based on model-informed precision dosing and used to evaluate efficacy and safety. Therefore, we predicted VCM concentrations in individual methicillin-resistant Staphylococcus aureus-infected patients using existing a physiologically based pharmacokinetic (PBPK) model and 1- and 2-compartment population pharmacokinetic (PPK) models and confirmed and verified the accuracy of the PBPK model in estimating VCM concentrations with the PPK model. METHODS: The subjects of the study are 20 patients, and the predicted concentrations were evaluated by comparing the observed and predicted trough and peak values of VCM concentrations for individual patients. RESULTS: The results showed good correlation between the observed and predicted trough and peak concentrations of VCM was observed generally in the PBPK model, R2 values of 0.72, 0.62, and 0.40 with trough values of 0.49, 0.40, and 0.34 with peak values for PBPK model, 1-compartment, and 2-compartment model, respectively. CONCLUSIONS: Although the performance of the PBPK model is not as predictive as the PPK model, generally similar predictive trends were obtained, suggesting that it may be a valuable tool for rapid and accurate prediction of AUC for VCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
- Department of Pharmacy, Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan.
- Laboratory of Pharmacometrics and Systems Pharmacology Keio Frontier Research and Education Collaboration Square (K-FRECS) at Tonomachi, Keio University Kawasaki, Kanagawa, 210-0821, Japan.
- AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
- Department of Pharmacy, Tokyo Women's Medical University Hospital, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan. Electronic address: hamada.yukihiro@twmu.ac.jp.
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Maruyama, T., Kimura, T., Ebihara, F., Kasai, H., Matsunaga, N., & Hamada, Y. (2023). Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2023.08.017
Vancouver
Maruyama T, Kimura T, Ebihara F, Kasai H, Matsunaga N, Hamada Y. Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection. Journal of Infection and Chemotherapy. 2023. doi:10.1016/j.jiac.2023.08.017
BibTeX
@article{Maruyama2023,
author = {Maruyama, Takumi and Kimura, Toshimi and Ebihara, Fumiya and Kasai, Hidefumi and Matsunaga, Nobuaki and Hamada, Yukihiro},
title = {Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection},
journal = {Journal of Infection and Chemotherapy},
year = {2023},
doi = {10.1016/j.jiac.2023.08.017}
}
EUVIMED